Literature DB >> 21342245

Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy.

A Sallam1, P H Scanlon, I M Stratton, V Jones, C N Martin, M Brelen, R L Johnston.   

Abstract

AIMS: To compare agreement level and identify reasons for disagreement between grading of mydriatic digital photographs in a diabetic retinopathy screening service and hospital eye service biomicroscopy grading.
METHODS: Structured examination findings leading to automatically calculated National Screening Committee grades recorded on an electronic medical record system in the hospital eye service at the first clinic visit after diabetic retinopathy screening service referral between April 2006 and November 2007 were retrospectively compared with the grade at the screening visit that prompted referral. In cases of disagreement, screening images were reviewed.
RESULTS: Data on 452 eyes (226 patients) were analysed. For retinopathy, hospital eye service slit-lamp biomicroscopy grades were: R0 (no diabetic retinopathy) in 63 eyes; R1 (background retinopathy) in 251 eyes; R2 (pre-proliferative) in 129 eyes and R3 (proliferative) in nine eyes. Diabetic retinopathy screening service grades were in agreement in 350 eyes (77.4%), showed a lower grade in 59 eyes and a higher grade in 43. Agreement was moderate (κ=0.60). The most common reason for disagreement was overgrading of R1 by clinicians. Hospital eye service biomicroscopy maculopathy grades were: M0 (no maculopathy) in 366 eyes and M1 (maculopathy) in 86 eyes. Diabetic retinopathy screening service grades were in agreement in 327 eyes (72.3%), showed a lower grading in five eyes and a higher grade in 120 eyes. Agreement was moderate (κ=0.41). The commonest cause for disagreement was clinicians failing to identify fine macular exudates.
CONCLUSIONS: This study of routine clinical services demonstrates moderate agreement between non-medical grading of mydriatic digital retinal photography images and hospital slit-lamp biomicroscopy grading of patients referred with diabetic retinopathy. The majority of errors in grading were attributable to errors by hospital doctors, usually in the direction of under-grading which could be a potential source of clinical risk if treatment is delayed.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342245     DOI: 10.1111/j.1464-5491.2011.03273.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?

Authors:  G S Negretti; R Amin; L Webster; C A Egan
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

2.  Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population.

Authors:  Shu Liang; Min Pan; Nan Hu; Yu-Yu Wu; Hui Chen; Jian-Hua Zhu; Huai-Jin Guan; Ai-Min Sang
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

3.  Understanding inherent image features in CNN-based assessment of diabetic retinopathy.

Authors:  Roc Reguant; Søren Brunak; Sajib Saha
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

4.  Grader agreement, and sensitivity and specificity of digital photography in a community optometry-based diabetic eye screening program.

Authors:  Luckni Sellahewa; Craig Simpson; Prema Maharajan; John Duffy; Iskandar Idris
Journal:  Clin Ophthalmol       Date:  2014-07-17

5.  Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.

Authors:  V Manjunath; V Papastavrou; D H W Steel; G Menon; R Taylor; T Peto; J Talks
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

6.  Comparison of Optomap ultrawide-field imaging versus slit-lamp biomicroscopy for assessment of diabetic retinopathy in a real-life clinic.

Authors:  Robert M J Purbrick; Shahrnaz Izadi; Ankur Gupta; N Victor Chong
Journal:  Clin Ophthalmol       Date:  2014-07-29

7.  Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.

Authors:  Amber A van der Heijden; Michael D Abramoff; Frank Verbraak; Manon V van Hecke; Albert Liem; Giel Nijpels
Journal:  Acta Ophthalmol       Date:  2017-11-27       Impact factor: 3.761

8.  Eye care infrastructure and human resources for managing diabetic retinopathy in India: The India 11-city 9-state study.

Authors:  Clare E Gilbert; R Giridhara Babu; Aashrai Sai Venkat Gudlavalleti; Raghupathy Anchala; Rajan Shukla; Pant Hira Ballabh; Praveen Vashist; Srikrishna S Ramachandra; Komal Allagh; Jayanti Sagar; Souvik Bandyopadhyay; G V S Murthy
Journal:  Indian J Endocrinol Metab       Date:  2016-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.